Investments†—73.9%
|
| Investment
Type
|
|
| Acquisition
Date
|
| Cost
|
| Fair
Value
|
Direct Investments—50.3%
|
Direct Equity—32.0%
|
Germany—3.7%
|
Information Technology—3.7%
|
Fremman 1 MM Co-investment 7 Rocket SCSp*(1)(2)(3)(4)(5)
|
| Limited Partnership Interest
| 02/13/2024
|
| $ 951,727
|
| $ 893,415
|
Luxembourg—4.1%
|
Information Technology—4.1%
|
Stirling Square Capital Partners Eagle Co-Investment SCSp*(2)(3)(4)(5)
|
| Limited Partnership Interest
| 11/13/2023
|
| 1,012,232
|
| 1,004,480
|
United States—24.2%
|
Consumer Discretionary—4.7%
|
BPCP NSA Holdings, Inc. Class A Preferred Stock, 8.00%*(1)(2)(4)(5)(6)
|
| Preferred Stock
| 05/15/2024
|
| 858,275
|
| 858,275
|
BPCP NSA Holdings, Inc. Common Stock*(1)(2)(4)(5)
|
| Common Stock
| 05/15/2024
|
| 286,091
|
| 286,091
|
Health Care—7.2%
|
Resurgens II Co-Invest C, L.P.*(2)(3)(4)(5)
|
| Limited Partnership Interest
| 11/15/2023
|
| 656,895
|
| 652,974
|
NanoVista*(1)(2)(3)(4)(5)
|
| Limited Partnership Interest
| 04/23/2024
|
| 1,145,300
|
| 1,111,253
|
Information Technology—5.3%
|
Chronos Capital Fund, L.P.*(1)(2)(3)(4)(5)
|
| Limited Partnership Interest
| 04/29/2024
|
| 1,125,606
|
| 1,301,189
|
Utilities—7.0%
|
Greenbelt Capital Partners Saber L.P.*(1)(2)(4)(5)
|
| Limited Partnership Interest
| 10/25/2023
|
| 1,250,000
|
| 1,701,074
|
|
|
|
|
|
|
| 7,286,126
|
| 7,808,751
|
Secondary Direct Equity—18.3%
|
Luxembourg—4.1%
|
Health Care—4.1%
|
Ourvita Build-Up SCSp*(1)(2)(3)(4)(5)
|
| Limited Partnership Interest
| 11/16/2023
|
| 723,297
|
| 1,002,150
|
United States—14.2%
|
Industrials—9.0%
|
VSC EV3 (Parallel) LP*(1)(2)(3)(4)(5)
|
| Limited Partnership Interest
| 12/19/2023
|
| 734,376
|
| 923,431
|
TRP Continuation Fund (Genox), LP*(1)(2)(3)(4)(5)
|
| Limited Partnership Interest
| 02/22/2024
|
| 1,095,745
|
| 1,263,026
|
Health Care—5.2%
|
KL Champion Blocker PI LLC*(1)(2)(4)(5)
|
| Limited Partnership Interest
| 05/01/2024
|
| 1,250,000
|
| 1,272,359
|
|
|
|
|
|
|
| 3,803,418
|
| 4,460,966
|